Joint Formulary & PAD

Tadalafil - Erectile dysfunction

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important
Preferred
2.5mg tadalafil is non-formulary.
 

Status 2

Non Formulary
Formulations :
  • 2.5mg ONCE DAILY
Associated Icons :
Restrictions / Comments :
Important
Once daily tadalafil 2.5mg is non-formulary. Sildenafil is 1st line. Tadalafil (10mg, 20mg or 5mg) is an alternative.

PAD Profile

ChemicalSubstance :
Tadalafil
Indication :
Erectile dysfunction
Group Name :
Keywords :
Phosphodiesterase type 5 inhibitors, ED, Impotence
Brand Names Include :
Cialis
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Tadalafil is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Erectile dysfunction.

Committee Recommendations (1)

The Surrey Heartlands APC have agreed the following update for tadalafil for erectile dysfunction:

Tadalafil "as required" dosing (10mg and 20mg) has a Green traffic light status. Tadalafil and sildenafil "as required" dosing are equally preferred treatment options.

Tadalafil once daily (5mg) has a Green traffic light status. If daily dosing is not tolerated, use "as required" dosing.

Tadalafil once daily (2.5mg) is non-formulary (very costly).

NOTE: SLS endorsement is still required for tadalafil prescribing on the NHS. Patients who do not meet the SLS criteria may purchase an over-the-counter product. 

Use in combination with any other oral / non-oral treatments for erectile dysfunction is not supported